Literature DB >> 1822342

Mapping of dystrophin brain promoter: a deletion of this region is compatible with normal intellect.

J T den Dunnen1, L Casula, A Makover, B Bakker, D Yaffe, U Nudel, G J van Ommen.   

Abstract

Using a mouse genomic fragment containing the brain-specific promoter region of the dystrophin gene, we have located the brain promoter 75-300 kb proximal of the muscle promoter. Within our DMD-families we detected a patient who lacks both the brain-specific and muscle-specific promoter sequences. The normal intellectual capabilities of the patient argue against an indispensable role of the brain-specific first exon in mental functioning. The possibility exists that a NH2-terminally truncated dystrophin has taken over the function of the normal dystrophins in brain and/or muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822342     DOI: 10.1016/0960-8966(91)90118-c

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

1.  Striking conservation of the brain-specific region of the dystrophin gene.

Authors:  J P Hugnot; H Gilgenkrantz; M Jeanpierre; J Chelly; J C Kaplan; A Kahn
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

2.  Brain- and muscle-type promoters of the dystrophin gene are selected in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid [correction of lymphoplastoid] cells.

Authors:  H Nishio; M Matsuo; Y Kitoh; N Narita; M Shimmoto; Y Suzuki; H Nakamura
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

Review 3.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.

Authors:  H Nishio; Y Takeshima; N Narita; H Yanagawa; Y Suzuki; Y Ishikawa; Y Ishikawa; R Minami; H Nakamura; M Matsuo
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks.

Authors:  C Vaillend; A Rendon; R Misslin; A Ungerer
Journal:  Behav Genet       Date:  1995-11       Impact factor: 2.805

6.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

7.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

8.  Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy.

Authors:  F Muntoni; M A Melis; A Ganau; V Dubowitz
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.